Search
Search Results
##search.searchResults.foundPlural##
-
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
2667PDF: 968HTML: 397TABLE: 168FIGURES: 206 -
RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA
1914PDF: 1592HTML: 14605Untitled: 184Untitled: 154 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10300PDF: 6186HTML: 21740 -
BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI
5111PDF: 2487HTML: 30077Antinori Tables 1,2,3: 314 -
EPIDEMIOLOGY OF MALARIA IN THE STATE OF QATAR, 2008-2015
1857PDF: 942HTML: 411 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1152PDF: 563HTML: 198 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
1720PDF: 1013HTML: 214 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3098PDF: 1374HTML: 5831Fig1-Ag-Pil: 192Ag-Pil Fig.2: 196 -
A MULTICENTER ICET-A STUDY ON AGE AT MENARCHE AND MENSTRUAL CYCLES IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA (TDT) WHO STARTED EARLY CHELATION THERAPY WITH DIFFERENT CHELATING AGENTS. Age at menarche and menstrual cycles in patients with transfusion-dependent thalassemia.
697PDF: 451HTML: 91 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1725PDF: 780HTML: 10204Figures 1,2,3: 150 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2701PDF: 886HTML: 341Preferred Reviewers: 188 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2086PDF: 800HTML: 907Patient’s family tree: 148 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1903PDF: 682HTML: 668Table1: patient's characteristics: 136Table 2: profile of each patient: 161 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3169PDF: 1485HTML: 392 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3154PDF: 1299HTML: 4104 -
THE TRAGEDY CAUSED BY FAKE ANTIMALARIAL DRUGS
2683PDF: 1036HTML: 1886 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1247PDF: 749HTML: 294 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4642PDF: 1506HTML: 2229Untitled: 187Untitled: 202Untitled: 209Untitled: 191Untitled: 192 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
610PDF: 478HTML: 198 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1862PDF: 703HTML: 677 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
1302PDF: 834HTML: 7904Untitled: 186 -
QUALITY OF LIFE IN PATIENTS WITH THALASSEMIA MAJOR AND INTERMEDIA IN KERMAN-IRAN (I.R.)
1599PDF: 723HTML: 2323Cover Letter: 155 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1199PDF: 450HTML: 18539Figure 1: 151Figure 2: 136Figure 3: 152Figure 4: 185Figure 5: 156 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2006PDF: 1003HTML: 15639COVER LETTER: 163 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3492PDF: 833HTML: 6693 -
THALIDOMIDE AMELIORATES ERYTHROPOIESIS AND IRON HOMEOSTASIS IN TRANSFUSION-DEPENDENT β-THALASSEMIA Thalidomide ameliorates erythropoiesis and iron homeostasis
1294PDF: 1368PDF: 986HTML: 186







